He & She MD vs Brello: pricing, coaching, and verification
He & She MD vs Brello is a comparison between a clearly documented GLP-1 program and a provider with limited verified public details. Quick verdict: He & She MD is the clearer choice if you want bundled coaching, clinician messaging and a stated introductory price; Brello requires you to confirm pricing, eligibility, pharmacy and renewal terms before enrolling.
Top differences at a glance
This comparison focuses on the most distinctive differences: pricing transparency and introductory rates, bundled coaching and clinician access, medication formats and regulatory notes, and the level of verified public detail available for each provider.
1. Pricing transparency and introductory rates
He & She MD publishes introductory rates and renewal structure: compounded semaglutide injections start at $139/month for the first six months, oral semaglutide and tirzepatide injections start at $199/month for the first six months. The site states those are six-month introductory rates that renew higher, and examples note renewals at regular six-month prices. Brello had no verified pricing on the captured landing page and current details were not published or could not be verified, so price and renewal terms must be confirmed directly with Brello.
2. Bundled coaching and clinician access
He & She MD explicitly bundles a coaching app with 1:1 clinician messaging, GLP-1-specific guidance and progress tracking at no extra cost. That bundling is a core selling point and the captured evidence lists those features multiple times. For Brello, the captured affiliate landing page contained no verified feature list, so whether coaching or app-based clinician messaging is included is not supplied.
View He & She MD coaching features
3. Medication formats and regulatory notes
He & She MD offers semaglutide injection, oral semaglutide, and tirzepatide injection as documented options, with medication produced in USP-compliant, state-regulated pharmacies but noted as not reviewed by the FDA for safety, efficacy, or quality. The company states medications require consultation and prescription by a clinician through its platform and that not all customers will qualify for a prescription. For Brello, the captured evidence only records that treatment is available when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
4. Public verification and captured landing-page evidence
He & She MD content was captured and reviewed with specific landing-page evidence including pricing details, shipping, and the app bundle. Brello’s captured affiliate landing page did not yield readable evidence for pricing, features, shipping, or state coverage, and the current details were not published or could not be verified. The comparison source recommends confirming Brello eligibility, medication, total cost, renewal terms and state availability before enrollment.
Comparison table
| Criteria | He & She MD | Brello |
|---|---|---|
| Starting price | Semaglutide injection from $139/mo; oral semaglutide and tirzepatide from $199/mo (six-month intro) | $133 listed as starting price but details not verified on captured page |
| Coaching and clinician access | App with 1:1 clinician messaging and GLP-1 coaching included at no extra cost | Not verified on captured landing page |
| Medication formats | Semaglutide injection, oral semaglutide, tirzepatide injection | Not published or could not be verified |
| Regulatory note | Medications from USP-compliant, state-regulated pharmacies; compounded meds not reviewed by FDA | Compounded meds, when offered, are not FDA-approved and are not reviewed by FDA |
| Shipping and fees | Free expedited shipping; no membership fee; no insurance needed | Not verified on captured page |
How verification and eligibility differ
He & She MD provides specific captured claims about eligibility workflow, clinician consultation, and intro pricing with renewal examples. Brello’s captured evidence failed to verify pricing, eligibility, pharmacy or state coverage and explicitly advises confirming those items before enrolling. Where Brello’s details are not supplied, the comparison notes that verification with Brello is required.
Conclusion and who should choose which provider
For readers comparing He & She MD vs Brello, the decisive differences are transparency and documented bundling of coaching and clinician access. He & She MD supplies introductory pricing, a bundled coaching app and 1:1 clinician messaging alongside specific renewal examples. Brello’s public captured landing-page evidence was not verified for pricing, features, shipping or state coverage, and the provider is presented as requiring confirmation of eligibility, medication and total cost.
Start He & She MD eligibility check
Choose He & She MD if you want a documented introductory price, a coaching app with 1:1 clinician messaging included, and published renewal examples. Choose Brello if you will confirm pricing, eligibility, pharmacy and renewal terms directly with the provider because those details were not verified on the captured page.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
